| Literature DB >> 11412151 |
G O Skeie1, P K Lunde, O M Sejersted, A Mygland, J A Aarli, N E Gilhus.
Abstract
Some myasthenia gravis (MG) patients have antibodies against skeletal muscle antigens in addition to the acetylcholine receptor (AChR). A major antigen for these antibodies is the Ca2+ release channel of the sarcoplasmic reticulum the ryanodine receptor (RyR). These antibodies are found mainly in MG patients with a thymoma MG and correlate with severe MG symptoms. The antibodies recognize a region near the N-terminus on the RyR, which seems to be of importance for RyR regulation. The antibodies cause allosteric inhibition of RyR function in vitro, inhibiting Ca2+ release from sarcoplasmic reticulum.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11412151 DOI: 10.1046/j.1365-201x.2001.00841.x
Source DB: PubMed Journal: Acta Physiol Scand ISSN: 0001-6772